Long-Term Safety Study of Tafenoquine
Study sponsor: 60 Degrees Pharmaceuticals LLC
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2021-07-13Actual
Enrollment · participants600Actual
Source updated2026-04-17Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.